Dexamethasone Treatment in Patients With Severe COVID-19: A Propensity Score-Matched Study

During the coronavirus disease-2019 (COVID-19) pandemic, which was caused by the novel coronavirus, there is an ongoing controversy about the use of corticosteroids. This study aims to investigate the association between Dexamethasone treatment and clinical outcomes in patients with severe COVID-19...

Description complète

Détails bibliographiques

Auteurs principaux:	Mahnaz Montazeri, Marzieh Pazoki, Azar Hadadi, Melika Shafeghat, Abdolazim Veisizadeh, Mohammad Reza Khajavi, Farhad Najmeddin, Samira Kafan
Format:	Artigo
Langue:	Inglês
Publié:	Tehran University of Medical Sciences 2022-08-01
Collection:	Acta Medica Iranica
Sujets:	Coronavirus disease 2019 (COVID-19) Dexamethasone Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Corticosteroid Mortality
Accès en ligne:	https://acta.tums.ac.ir/index.php/acta/article/view/9967
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!